title: Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.
abstract: Several classes of antibiotics exert antimalarial activity. The mechanisms of action of antibiotics against malaria parasites have been unclear, and prior studies have led to conflicting results, in part because they studied antibiotics at suprapharmacological concentrations. We examined the antimalarial effects of azithromycin, ciprofloxacin, clindamycin, doxycycline, and rifampin against chloroquine-resistant (W2) and chloroquine-sensitive (3D7) Plasmodium falciparum strains. At clinically relevant concentrations, rifampin killed parasites quickly, preventing them from initiating cell division. In contrast, pharmacological concentrations of azithromycin, ciprofloxacin, clindamycin, and doxycycline were relatively inactive against parasites initially but exerted a delayed death effect, in which the progeny of treated parasites failed to complete erythrocytic development. The drugs that caused delayed death did not alter the distribution of apicoplasts into developing progeny. However, the apicoplasts inherited by the progeny of treated parasites were abnormal. The loss of apicoplast function became apparent as the progeny of antibiotic-treated parasites initiated cell division, with the failure of schizonts to fully mature or for erythrocyte rupture to take place. These findings explain the slow antimalarial action of multiple antibiotics.
authors: Department of Medicine, University of California San Francisco, San Francisco, CA 94143-0811, USA.
authors: Erica L
authors: EL
authors: Dahl
authors: Philip J
authors: PJ
authors: Rosenthal
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000962:Antimalarials / Q000494:pharmacology*; D004351:Drug Resistance; D005434:Flow Cytometry; D049452:Green Fluorescent Proteins / Q000378:metabolism; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D059005:Topoisomerase II Inhibitors
chemical_list: D000900:Anti-Bacterial Agents; D000962:Antimalarials; D011500:Protein Synthesis Inhibitors; D059005:Topoisomerase II Inhibitors; D049452:Green Fluorescent Proteins
references: Mol Microbiol. 2002 Jul;45(2):533-42
references: 12123462
references: J Clin Invest. 1995 Jan;95(1):367-76
references: 7814637
references: Antimicrob Agents Chemother. 2001 Jun;45(6):1746-50
references: 11353621
references: Antimicrob Agents Chemother. 2007 Feb;51(2):651-6
references: 17116669
references: Antimicrob Agents Chemother. 2002 Aug;46(8):2315-20
references: 12121898
references: FEBS Lett. 1997 Apr 7;406(1-2):123-5
references: 9109400
references: Science. 2003 Jan 31;299(5607):705-8
references: 12560551
references: FEBS Lett. 2002 Mar 27;515(1-3):71-4
references: 11943197
references: J Biol Chem. 2007 Jan 26;282(4):2494-504
references: 17110371
references: Mol Microbiol. 2002 Mar;43(5):1309-18
references: 11918815
references: EMBO J. 2001 Feb 1;20(3):330-9
references: 11157740
references: Curr Issues Mol Biol. 2005 Jan;7(1):57-79
references: 15580780
references: J Infect Dis. 2005 May 15;191(10):1582-8
references: 15838784
references: Drug Discov Today. 2001 Nov 15;6(22):1151
references: 11700215
references: Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):1-11
references: 11425172
references: J Mol Biol. 1996 Aug 16;261(2):155-72
references: 8757284
references: Am J Trop Med Hyg. 2001 May-Jun;64(5-6):223-8
references: 11463107
references: Nature. 1997 Nov 27;390(6658):407-9
references: 9389481
references: Am J Trop Med Hyg. 2006 Mar;74(3):401-6
references: 16525097
references: Int J Parasitol. 1995 Apr;25(4):531-2
references: 7635629
references: Clin Infect Dis. 2006 Nov 15;43(10):1264-71
references: 17051490
references: Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):302-3
references: 10492765
references: J Biol Chem. 1997 Jan 24;272(4):2046-9
references: 8999899
references: Mol Biochem Parasitol. 1989 May 1;34(2):109-15
references: 2651921
references: N Engl J Med. 2005 Apr 14;352(15):1565-77
references: 15829537
references: Br J Clin Pharmacol. 2000 Jan;49(1):32-8
references: 10606835
references: DNA Cell Biol. 1997 Dec;16(12):1483-92
references: 9428797
references: Malar J. 2007 May 25;6:70
references: 17531088
references: Biol Rev Camb Philos Soc. 2005 Feb;80(1):129-53
references: 15727041
references: Am J Trop Med Hyg. 1983 Mar;32(2):221-5
references: 6340539
references: Nature. 2002 Oct 3;419(6906):498-511
references: 12368864
references: EMBO J. 2000 Apr 17;19(8):1794-802
references: 10775264
references: Antimicrob Agents Chemother. 2005 Apr;49(4):1622-5
references: 15793155
references: Gene. 2001 Dec 12;280(1-2):19-26
references: 11738814
references: Am J Trop Med Hyg. 2006 Mar;74(3):407-12
references: 16525098
references: J Parasitol. 1979 Jun;65(3):418-20
references: 383936
references: Nature. 2005 Mar 10;434(7030):214-7
references: 15759000
references: J Infect Dis. 2004 Nov 1;190(9):1534-40
references: 15478056
references: Antimicrob Agents Chemother. 2006 Sep;50(9):3124-31
references: 16940111
references: Nat Rev Microbiol. 2004 Mar;2(3):203-16
references: 15083156
references: Antimicrob Agents Chemother. 1995 Jul;39(7):1530-7
references: 7492099
references: J Infect Dis. 1984 Dec;150(6):904-11
references: 6389719
references: Antimicrob Agents Chemother. 1985 Jan;27(1):21-7
references: 3885844
references: Antimicrob Agents Chemother. 2007 Jan;51(1):307-16
references: 17060533
references: J Biol Chem. 2007 Mar 2;282(9):6388-97
references: 17194705
references: Mol Biochem Parasitol. 2007 Apr;152(2):181-91
references: 17289168
references: Mol Microbiol. 2005 Apr;56(1):81-9
references: 15773980
references: Nature. 1978 Jun 22;273(5664):621-2
references: 351412